List view / Grid view
30 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
30 July 2018 | By European Pharmaceutical Review
Inhibiting protein kinase C-alpha was shown to be a pivotal step towards restoring the damage done by nephritis...
16 July 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox...
5 July 2018 | By European Pharmaceutical Review
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury...
26 June 2018 | By European Pharmaceutical Review
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge...
22 June 2018 | By European Pharmaceutical Review
A study has found a novel mechanism underlying stable, durable blood sugar control...
18 June 2018 | By European Pharmaceutical Review
Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open...
13 June 2018 | By European Pharmaceutical Review
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
12 June 2018 | By European Pharmaceutical Review
Findings may represent simple and potentially low-cost intervention...
5 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review), zae
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
1 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
People who take immunosuppressants are less likely to develop Parkinson's disease...
31 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
An FDA-approved drug for lymphoma and leukaemia may also help treat the most common - and deadliest type of brain tumour...
31 May 2018 | By European Pharmaceutical Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
30 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Protein inhibits inflammatory response underlying chronic pain processing may provide an alternative to opioids for severe, persistent pain...
29 May 2018 | By European Pharmaceutical Review
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumours...
Follow: